Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Gastrointestinal Infections specialty page provides gastrointestinal infection-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


First English FMT Bank Sees High Clinical Response Rate
Results from England’s first licensed FMT stool bank are now available.
Electronic Alerts Aid in <i>C diff</i> Diagnostic Stewardship
An electronic alert that aids in diagnostic stewardship may be helpful in reducing inappropriate testing for C diff, according to a new study.  
Can Enteral Vancomycin <i>C Diff</i> Prophylaxis Improve Outcomes in HSCT Recipients?
Using enteral vancomycin for C diff prophylaxis may be the key to reducing morbidity and improving outcomes in pediatric and young adult recipients of HSCT.
Phase 3 Clinical Trial of Historic Microbiota Treatment for <i>C Diff</i> Completes Enrollment
Rebiotix has announced that it has completed enrollment of a phase 3 clinical trial for RBX2660.
Rotavirus Vaccination is Cost Effective and Saves Lives, Analysis Finds: Public Health Watch
Jab could save 600,000 lives, and hundreds of millions in health care costs.
Epigenetics Mediates Sporulation and Pathogenesis in <i>C Diff</i>
DNA methyltransferase, an epigenetic process, has been found to mediate sporulation and pathogenesis in C diff.
Bimodal Release Oral Ondansetron Shows Promise in Phase 3 Study
Intravenous treatment of acute gastroenteritis can be costly and uncomfortable. A phase 3 clinical trial showed positive results for a bimodal release oral ondansetron tablet, finding the drug effective in treating nausea and vomiting.  
FDA Approves RHB-105 to Treat <i>H Pylori</i>
RHB-105 (Talicia) is the only rifabutin-based therapy approved for the treatment of H pylori infection and is designed to address the high resistance of H pylori bacteria to current clarithromycin-based standard-of-care therapies. 
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?